Company Filing History:
Years Active: 2020-2024
Title: Carmen Theek: Innovator in Diagnostic Methods for SLE
Introduction
Carmen Theek is a notable inventor based in Herdecke, Germany. He has made significant contributions to the field of diagnostics, particularly in relation to systemic lupus erythematosus (SLE). With a total of 2 patents, his work focuses on identifying markers that can aid in the diagnosis and stratification of SLE patients.
Latest Patents
Carmen Theek's latest patents revolve around methods for identifying markers for systemic lupus erythematosus (SLE). These inventions are designed to differentiate between SLE and other autoimmune diseases, as well as between different subgroups of SLE. The patents also encompass panels, diagnostic devices, and test kits that utilize these markers for diagnosis, prognosis, and therapy control in SLE. Furthermore, the inventions include methods for screening and validating active substances for application in SLE subgroups.
Career Highlights
Carmen Theek is currently associated with Oncimmune Germany GmbH, where he continues to advance his research and innovations in the field of diagnostics. His work has the potential to significantly impact the way SLE is diagnosed and treated.
Collaborations
Carmen collaborates with esteemed colleagues such as Peter Schulz-Knappe and Petra Budde, who contribute to the research and development of innovative diagnostic methods.
Conclusion
Carmen Theek's contributions to the field of diagnostics for systemic lupus erythematosus highlight his role as a key innovator. His patents and ongoing work at Oncimmune Germany GmbH are paving the way for improved diagnostic tools and therapies for SLE patients.